Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2011-11-21 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages 20.0KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors, officers, or significant shareholders. The document details transactions involving shares and derivative securities, including dates, amounts, and ownership types. It is not a financial report, earnings release, or management discussion, but a regulatory filing specifically reporting insider transactions. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2011-11-21 English
Change of Director`s Interest Notice 2 pages 20.6KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors, officers, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, and ownership information. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 5640 characters, which is sufficient to contain the full Form 4 details rather than just an announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2011-11-21 English
Amended Shares Outstanding as reported in Form 10-Q 6 pages 94.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 10-Q/A (Amendment No. 1)' which indicates it is an amendment to a quarterly report (Form 10-Q). The text states it is an amendment to the quarterly report for the period ended September 30, 2011. The document primarily contains a correction regarding the number of shares outstanding and includes certifications from the CEO and CFO as required by SEC rules. There is no substantive financial data or analysis presented beyond the correction and certifications. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing a 10-Q, should be classified as Regulatory Filings (RNS). The document length is 5761 characters, which is relatively short and focused on the amendment and certifications rather than the full quarterly report. Therefore, this document is best classified as a Regulatory Filing (RNS).
2011-11-21 English
Change of Director`s Interest Notice 3 pages 23.7KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors and officers. The document details transactions in the company's stock by an executive chairman and CEO, including dates, amounts, and nature of ownership. This type of filing is specifically related to insider share transactions by company directors and executives, which corresponds to the category 'Director's Dealing'. The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification.
2011-11-15 English
Form 10Q for QTR ended September 30, 2011 82 pages 552.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended September 30, 2011. It contains detailed unaudited condensed consolidated financial statements including balance sheets, income statements, cash flow statements, notes to financial statements, and management's discussion and analysis. The length of the document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of quarterly financial data and the SEC form designation 10-Q clearly identifies this as an Interim / Quarterly Report. Q1 2012
2011-11-03 English
Becoming a substantial holder 4 pages 1.4MB
Regulatory Filings
2011-11-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.